Company intelligence / Profile preview
Dynavax Technologies
Berkeley, California, United Statesdynavax.com ↗
- Ownership
- Public · DVAX
- Employees
- ~250
- Development stage
- Commercial
01
Overview
Dynavax's HEPLISAV-B, a hepatitis B vaccine, is commercially available and FDA-approved since 2017. The CpG 1018 adjuvant powers both their commercial hepatitis B vaccine and multiple vaccines in collaboration addressing infectious diseases and oncology. As of 2023/24, they have active early-phase clinical programs in cancer immunotherapy and other vaccine platforms.
- Therapeutic areas
- OncologyInfectious DiseasesPulmonology
- Modalities
- VaccineBiologicAdjuvant
- Industry
- Biotech
02
Drug pipeline
27 assets26 more assets in the full pipeline.
Request access →03
Partnerships
Multiple vaccine developers leveraging CpG 1018 adjuvant (especially during COVID-19 pandemic)Collaborative relationships in oncology and infectious diseases (specific names not listed in search results)
Beyond the preview
Go deeper on Dynavax Technologies.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Dynavax Technologies.